Journal of Clinical Oncology

Phase II study of alisertib, irinotecan, and temozolomide in children with relapsed and refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.

Journal of Clinical Oncology

Steven G. DuBois, Araz Marachelian, Elizabeth Fox, Rachel A. Kudgus, Joel M. Reid, Susan G. Groshen, Jemily Malvar, Rochelle Bagatell, Lars M. Wagner, John M. Maris, Randall Hawkins, Jesse Courtier, Hollie Lai, Fariba Goodarzian, Hiroyuki Shimada, Najee Boucher, Scarlett Czarnecki, Denice D Tsao-Wei, Katherine K. Matthay, Yael P. Mosse

Phase II study of 131 I-MIBG with vincristine and 5 days of irinotecan for patients with relapsed or refractory neuroblastoma.

Journal of Clinical Oncology

Steven G. DuBois, M. Shelly Allen, Melissa Bent, Joan Hilton, Fabienne Hollinger, Jesse Courtier, Randall Hawkins, Yael P. Mosse, Katherine K. Matthay